Description
Gene therapy targeting CYP46A1 was proposed but the therapeutic window remains undefined. Excessive cholesterol depletion could impair synaptic function, while insufficient reduction may not affect amyloid processing, making dosing critical for safety and efficacy.
Source: Debate session sess_SDA-2026-04-01-gap-lipid-rafts-2026-04-01 (Analysis: SDA-2026-04-01-gap-lipid-rafts-2026-04-01)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:37.742475+00:00”, “resolution_summary”: “Resolved by hypothesis h-2600483e: CYP46A1 Overexpression Gene Therapy. Supporting evidence includes debate sess_SDA-2026-04-12-gap-debate-20260410-112842-e2dec0d7.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-2600483e”, “title”: “CYP46A1 Overexpression Gene Therapy”, “score”: 0.26, “reason”: “27 token overlaps; entity overlap: cyp46a1”, “analysis_id”: “SDA-2026-04-01-gap-lipid-rafts-2026-04-01”, “target_gene”: “CYP46A1”, “target_pathway”: “Cholesterol 24-hydroxylase / brain cholesterol turnover”, “disease”: “neurodegeneration”, “composite_score”: 0.73, “confidence_score”: 0.85, “status”: “promoted”, “pubmed_evidence_ids”: [“25855610”, “26141492”, “27033548”, “28744197”, “30559369”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-12-gap-debate-20260410-112842-e2dec0d7”, “title”: “The debate proposed bioenergetic gradients drive transfer but didn’t identify the specific molecular sensors or trafficking machinery that determines which neurons receive mitochondria. Understanding these mechanisms is essential for therapeutic targeting.\n\nSource: Debate session sess_SDA-2026-04-01-gap-v2-89432b95 (Analysis: SDA-2026-04-01-gap-v2-89432b95)”, “score”: 0.381, “reason”: “8 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-112842-e2dec0d7”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-debate-20260410-113045-27c7b314_20260421-011124”, “title”: “The debate revealed conflicting evidence about whether TRPML1 activation rescues or worsens lysosomal function, with studies showing both therapeutic effects and calcium depletion toxicity. The therapeutic window and dose-response relationship remain undefined, preventing clinical translation.\n\nSource: Debate session sess_SDA-2026-04-01-gap-011 (Analysis: SDA-2026-04-01-gap-011)”, “score”: 0.371, “reason”: “8 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-16-gap-debate-20260410-113045-27c7b314”, “quality_score”: 0.72, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-debate-20260410-113045-27c7b314”, “title”: “The debate revealed conflicting evidence about whether TRPML1 activation rescues or worsens lysosomal function, with studies showing both therapeutic effects and calcium depletion toxicity. The therapeutic window and dose-response relationship remain undefined, preventing clinical translation.\n\nSource: Debate session sess_SDA-2026-04-01-gap-011 (Analysis: SDA-2026-04-01-gap-011)”, “score”: 0.371, “reason”: “8 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-16-gap-debate-20260410-113045-27c7b314”, “quality_score”: 0.46, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-gap-debate-20260410-112848-7ba6c2e1”, “title”: “The debate revealed conflicting evidence about C1q’s role - some studies show it drives synaptic loss while others suggest it facilitates protective amyloid clearance. This fundamental mechanistic uncertainty undermines therapeutic targeting strategies.\n\nSource: Debate session sess_SDA-2026-04-01-gap-v2-691b42f1 (Analysis: SDA-2026-04-01-gap-v2-691b42f1)”, “score”: 0.362, “reason”: “8 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-12-gap-debate-20260410-112848-7ba6c2e1”, “quality_score”: 0.58, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-debate-20260410-112819-e40e0fa2_20260416-034924”, “title”: “The debate established that ceramide accumulation affects amyloid-β processing but didn’t resolve the spatial specificity of this mechanism. Understanding differential raft regulation could enable targeted interventions that preserve synaptic function while reducing amyloidogenic processing.\n\nSource: Debate session sess_SDA-2026-04-01-gap-lipid-rafts-2026-04-01 (Analysis: SDA-2026-04-01-gap-lipid-rafts-2026-04-01)”, “score”: 0.358, “reason”: “8 token overlaps; entity overlap: sda-2026-04-01-”, “analysis_id”: “SDA-2026-04-15-gap-debate-20260410-112819-e40e0fa2”, “quality_score”: 0.84, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}